Integral Health Asset Management’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History

Integral Health Asset Management’s Portfolio FMTX Stock Details FMTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-92,000	Closed	-$3.31M	–	93
2022 Q3	$3.31M	Sell	92,000 -38,051	-29%	-$502K	0.64%	54
2022 Q2	$896K	Buy	130,051 +40,051	+45%	+$281K	0.18%	61
2022 Q1	$837K	Buy	90,000 +15,000	+20%	+$160K	0.22%	66
2021 Q4	$1.07M	Buy	75,000 +15,000	+25%	+$260K	0.3%	65
2021 Q3	$1.39M	Buy	60,000 +15,000	+33%	+$355K	0.4%	63
2021 Q2	$1.12M	Buy	+45,000	New	+$1.21M	0.31%	64

Integral Health Asset Management's FMTX Position: Q4 2022 in Review

Integral Health Asset Management sold out of Forma Therapeutics Holdings, Inc. Common Stock (FMTX) in Q4 2022, closing a stake of 92,000 shares — an estimated $3.31M sold.

Integral Health Asset Management first reported a position in FMTX in Q2 2021 and held it in 6 quarters. The position peaked at $3.31M in Q3 2022. 0 funds tracked by Wall St. Rank hold FMTX as of Q4 2022.

Integral Health Asset Management reported no remaining Forma Therapeutics Holdings, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Integral Health Asset Management sold 92,000 Forma Therapeutics Holdings, Inc. Common Stock shares in Q4 2022, an estimated $3.31M.
Integral Health Asset Management first reported a position in Forma Therapeutics Holdings, Inc. Common Stock in Q2 2021 and held it in 6 quarters.
Integral Health Asset Management's Forma Therapeutics Holdings, Inc. Common Stock position peaked at $3.31M in Q3 2022.
0 funds tracked by Wall St. Rank held Forma Therapeutics Holdings, Inc. Common Stock as of Q4 2022.

Based on Integral Health Asset Management's 13F filing for Q4 2022, filed 13 Feb 2023.